[ET Net News Agency, 28 May 2024] UBS raised the target price for CSPC Pharma (01093) to
HKD10.1 from HKD9.3 and maintained the "buy" rating.
The research house said it revises up revenue growth assumption for 2024 (9.8% vs prior
6.8%). (rc)
28/05/2024 15:10
{I-bank focus}UBS raises CSPC Pharma (01093) to HKD10.1
[ET Net News Agency, 28 May 2024] UBS raised the target price for CSPC Pharma (01093) to
HKD10.1 from HKD9.3 and maintained the "buy" rating.
The research house said it revises up revenue growth assumption for 2024 (9.8% vs prior
6.8%). (rc)
Previous︰28/05/2024 15:51 {I-bank focus}Daiwa raises CSPC Pharma (01093) to HKD8
Next︰28/05/2024 09:31 {Hot Stocks}6 listed firms see price swing at 9:30am
30/05/2024 08:45 Summary of listed companies announcements (4)
29/05/2024 11:35 {Hot Stocks}CSPC PHARMA(01093) quoted at HK$6.81, down 3.1%
29/05/2024 08:45 Summary of listed companies announcements (5)
27/05/2024 13:45 {Hot Stocks}CSPC PHARMA(01093) quoted at HK$6.69, up 4.7%
27/05/2024 13:13 {Hot Stocks}CSPC PHARMA(01093) quoted at HK$6.59, up 3.1%
Remark: | Real time quote last updated: 17/07/2024 08:03 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service |